Fig 1: Cullin3 is indispensable for C1QBP‐mediated ferroptosis of mast cells. (A) Co‐IP was used to verify the interaction of C1QBP and Cullin3. (B) 5 μg/mL rhC1QBP, and equivalent amount of inactive recombinant C1QBP protein (rh‐inactive) were applied to incubate cultured mast cells. Post incubation for 24 h, cells were harvested and Western blotting was used to detect the expression of Cullin3 protein. Cullin‐3 siRNA (50 nM) and si‐NC (50 nM) were used to transfect mast cells. After transfection for 24 h, 5 μg/mL rhC1QBP and equivalent amount of inactive recombinant C1QBP protein (rh‐inactive) were applied to incubate cultured mast cells. Post incubation for 24 h, cells were harvested and applied in the following tests. (C, D) Western blotting was used to detect the expression of C1QBP, Cullin3, GPX4, SLC7A11, Nrf2 and HO‐1 proteins. (E) WAK‐Fe2+ Detection Kit was used to detect Fe2+ concentration. (F) PI staining was used to evaluate cell death. (G) Oxidative Sensitive Fluorescent Probe DCFH‐DA was used to evaluate contents of Lipid ROS. (H) TEM analysis of mitochondrial morphology in mast cells. Compared with Control *p < 0.05; **p < 0.01; compared with rhC1QBP, #p < 0.05.
Fig 2: Relationship of C1QBP expression level and survival rates of LUAD patients. (A) The association of C1QBP expression level and DFI, OS, DSS or PFI survival rate of LUAD patients. (B) The association of C1QBP expression level and OS, DSS or PFI survival rate in LUAD patients with different genders or T stages.
Supplier Page from Fine Biotech Co., Ltd. for Recombinant Human C1QBP